ArticleIDCases2026
Invasive pulmonary aspergillosis as a sentinel manifestation of good syndrome in a patient with thymoma.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Good syndrome is a rare adult-onset combined immunodeficiency associated with thymoma, characterized by hypogammaglobulinemia and impaired T-cell-mediated immunity. Opportunistic infections are a major cause of morbidity and mortality, and invasive aspergillosis may represent a severe but underrecognized manifestation. In some cases, it may serve as a sentinel presentation leading to the diagnosis of Good syndrome. Case presentation: A 52-year-old man presented with a history of thymoma and myasthenia gravis, chronic sinopulmonary infections, cytomegalovirus colitis, chronic diarrhea, and cytopenia. Chest CT scan revealed multiple pulmonary nodules and tree-in-bud opacities. Bronchoalveolar lavage, galactomannan assay, and lung biopsy confirmed Aspergillus infection. Subsequent comprehensive immunologic evaluation demonstrated hypogammaglobulinemia, markedly reduced peripheral B cells (CD19⁺), and impaired T-cell immunity, consistent with Good syndrome. Conclusion: Invasive pulmonary aspergillosis can serve as a key sentinel manifestation leading to the diagnosis of Good syndrome in patients with thymoma. Early recognition of opportunistic infections and prompt immunological assessment are critical for timely treatment and improved clinical outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.